Daily non-political popular news in brief.

Teens overlooked in cancer research

McMaster University pediatric cancer specialist Dr. Ronald Barr says the teen gap in cancer care has been overlooked for far too long. Statistics show that gains in survival rates for teenagers and young adults (age 15-29) with cancer are dismal when compared to those for youngsters and older adults with the disease.Barr is one of the editors of the recently released and first definitive document on the incidence, survival and mortality of 15-29 year-olds.

Read more »

Keywords: teens, overlooked, cancer, research, teen

« Previous | Next »

Similar news on "Teens overlooked in cancer research":

1. Blindness from smoking terrifies teens, but few realize the two are linked
   02-05-2007 · EurekAlert!
   Teenagers fear blindness more than lung cancer or stroke, but nine out of 10 don't know that smoking can rob them of their sight in later life, reveals research published ahead of print in the British Journal of Ophthalmology. The findings are based on the responses of 260 clubbers aged between 16 and 18, collected at four UK venues in Bournemouth, Winchester, Manchester and Southampton.
   Similar news · Read more »
   
2. U of M research finds disordered eating less common among teen girls who regularly eat family meals
   01-08-2008 · EurekAlert!
   Adolescent girls who frequently eat meals with their families appear less likely to use diet pills, laxatives, or other extreme measures to control their weight five years later, according to research led by Dianne Neumark-Sztainer, PhD, MPH, RD, lead investigator of Project Eating Among Teens at the University of Minnesota School of Public Health.
   Similar news · Read more »
   
3. Other highlights in the February 21 JNCI
   02-20-2007 · EurekAlert!
   Also in the February 21 JNCI are a new screening method for those at risk for a hereditary colorectal cancer, a mouse study of low-dose bisphosphonates' antitumor effects, and research on a protein that is active in metastasis suppression.
   Similar news · Read more »
   
4. Drug industry increasingly influences breast cancer research
   02-26-2007 · EurekAlert!
   Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
   Similar news · Read more »
   
5. A new pharmaceutical drug that halts progress of metastatic kidney cancer
   03-01-2007 · EurekAlert!
   Research has shown the efficacy of a pharmaceutical drug known as sunitinib which halts progress of metastatic kidney cancer. The work was published recently in the prestigious international medical journal, the New England Journal of Medicine.
   Similar news · Read more »
   
6. Researchers from the University of Navarra analyze new kinds of cancer-fighting antibodies
   03-06-2007 · EurekAlert!
   Two researchers from the University Hospital and the Center for Applied Medical Research (CIMA) from the University of Navarra have published an article in Nature Cancer Reviews.
   Similar news · Read more »
   
7. Chromium 6: A killer compound with an improbable trigger
   03-12-2007 · EurekAlert!
   Chromium 6, the cancer-causing compound that sparked the legal crusade by Erin Brockovich, can be toxic in tiny doses. Brown University scientists have uncovered the unlikely culprit: vitamin C. In new research, the Brown team shows that when vitamin C reacts with even low doses of chromium 6 inside human cells, it creates high levels of cancer-causing DNA damage and mutations.
   Similar news · Read more »
   
8. Inflammation may play role in metastasis of prostate cancer
   03-18-2007 · EurekAlert!
   Research at the UCSD School of Medicine strongly suggests that inflammation associated with the progression of tumors actually plays a key role in the metastasis of prostate cancer.
   Similar news · Read more »
   
9. Discoveries thrust cancer-initiating stem cells into a larger role in cancer biology and treatment
   04-18-2007 · EurekAlert!
   Recent discoveries about the role of stem cells in cancer have altered the landscape of cancer research. With each new study, scientists are learning more about cancer-initiating properties of stem cells at organ sites and throughout the body. Increasingly, stem cells are examined as the cause -- and potential target of treatment -- for many, if not all, cancers.
   Similar news · Read more »
   
10. 'Wrapping' Gleevec fights drug-resistant cancer
    05-01-2007 · EurekAlert!
    A study in this week's Cancer Research finds the anti-cancer drug Gleevec is far more effective against a drug-resistant strain of cancer when it wraps the target with a molecular bandage that seals out water from a critical area. The wrapping version of the drug -- known as WBZ-7 -- was created, produced and tested by three research teams from Rice University and the University of Texas M. D. Anderson Cancer Center in Houston.
    Similar news · Read more »